Virtual Event: A Path to Improving Cardiovascular Disease Outcomes in the US: Lessons Learned from a Public Health Crisis


After decades of downward trends, cardiovascular disease (CVD) – America’s number one cause of death – is on the rise. The onset of the COVID-19 pandemic has resulted in a monumental and dangerous confluence of epidemics in part due to mass disruptions in diagnosis and treatment of serious chronic diseases like CVD.

While there has been rapid progress by industry, governments, and other stakeholders to address the pandemic, it is critical to apply the same urgency, ingenuity and collaboration to tackle the chronic diseases and conditions that pose a threat to our society – including leveraging population health approaches that aim to reduce CVD morbidity and mortality and contribute to meaningful, enduring change for generations to come.


  • Rep. Larry Bucshon, MD, U.S. House of Representatives (R-IN), Cardiothoracic surgeon, Doctors Caucus
  • Rep. Linda Sanchez, U.S. House of Representatives (D-CA)
  • Rep. Billy Mitchell, Georgia House of Representatives (D)
  • Celina Gorre, MPA, MPH, Chief Executive Officer, WomenHeart
  • Sue Koob, MPA, Chief Executive Officer, Preventive Cardiovascular Nurses Association
  • Mark McClellan, MD, PhD, Director, Duke Margolis Center for Health Policy
  • Vas Narasimhan, MD, Chief Executive Officer, Novartis
  • Anand Parekh, MD, Chief Medical Advisor, Bipartisan Policy Center
  • Richard Williams, MD, Cardiovascular Committee Representative, National Medical Association, Founder of Association of Black Cardiologists
  • Alec Lee, Director of Healthcare Research, FrontierView, Part of FiscalNote
  • David Nash, MD, MBA, Founding Dean Emeritus, Jefferson College of Population Health

Watch On-Demand

Past Events